Synecor
Alternative Names: RL 6893Latest Information Update: 26 Apr 1995
At a glance
- Originator Aventis
- Class Antihypertensives
- Mechanism of Action ACE inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 26 Apr 1995 Discontinued-Preclinical for Hypertension in USA (Unknown route)